At the crossroads of innovation and equity, Josette Gbemudu and Merck are helping rewrite the narrative for breast cancer ...

New research presented at the 2025 American Society for Clinical Oncology’s (ASCO) annual meeting has shed light on the ...

ASCO Data Shows New Therapy Keeps Myeloma Patients in Remission for 5+ Years. Here's what you need to know about the ...

At the 2025 ASCO (American Society of Clinical Oncology) Annual Meeting, Dr. Armenian presented findings from the session ...

When you’re living with diabetes, you have to be careful. Here are 10 low-sugar marinades that still bring the flavor.

Tryptyr, a new dry eye treatment, is approved. Learn why Black participation in clinical trials is vital for effective, ...

At the heart of innovation is T-win®, a groundbreaking vaccine platform that could change how we treat cancer.

Yelak Biru was diagnosed with multiple myeloma at 25 and given just a few years to live. Thirty years later, he's thriving.

A study looked at the best ways researchers can approach clinical trials on social media to encourage more people to sign up.

Living with TD? Let’s dive into the top five leading therapies for tardive dyskinesia you’ve probably never even heard ...

The longtime HIV and AIDS activist Hydeia Broadbent who was born HIV-positive has passed away at the age of 39. Her legacy ...

Health equity has been an elusive goal for many Black Americans. For decades, systemic inequalities in healthcare access, coverage, and quality have disproportionately affected Black communities.